Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
spinal cord stimulation
MedTech
Medtronic inks $650M deal for SPR Therapeutics
Medtronic is expanding its pain portfolio with a $650 million deal for SPR Therapeutics and its temporary peripheral nerve stimulation technology.
Ayla Ellison
May 20, 2026 4:54pm
Globus Medical to buy neurostim developer Nevro for $250M
Feb 10, 2025 10:51am
FDA approves Medtronic’s closed-loop spinal cord stimulator
Apr 26, 2024 11:31am
FDA expands OK for Boston Sci WaveWriter spinal cord stimulators
Feb 6, 2024 12:28pm
Medtronic touts study success for new spinal cord stimulators
Jan 19, 2024 12:00pm
Spinal cord stimulators boost balance in foot amputees: study
Dec 15, 2023 1:35pm
